logo

Revolutionizing AI in drug discovery via innovative molecular representation paradigms

Sector: Chemical (Industrial) • Location: Netherlands

Source: EU Funding & Tenders Portal

Project
Ongoing

Artificial intelligence (AI) in the form of deep learning is driving unprecedented progress in numerous fields, e.g., for protein structure prediction and organic reaction planning. In drug discovery and chemical biology, such progress is an “evolution” rather than a revolution: several tasks still await to be solved by AI, e.g., accurate structure-activity and activity-cliff prediction, and desig

Project Information FAQ

Project Information

3 Q
The project “Revolutionizing AI in drug discovery via innovative molecular representation paradigms” is an infrastructure initiative in the Chemical (Industrial) sector, located in Netherlands. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

ongoing

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

Artificial intelligence (AI) in the form of deep learning is driving unprecedented progress in numerous fields, e.g., for protein structure prediction and organic reaction planning. In drug discovery and chemical biology, such progress is an “evolution” rather than a revolution: several tasks still await to be solved by AI, e.g., accurate structure-activity and activity-cliff prediction, and design of structurally innovative chemical matter. Increasingly complex deep learning approaches are leading to progressively smaller gains in model capabilities, calling for a revolution in AI for drug discovery. The springboard for this project is a striking observation: while novel deep learning algorithms are in continuous development, the input ‘raw’ molecular representations they rely on (e.g., SMILES strings and molecular graphs) have not considerably changed in the last four decades – limiting the amount and quality of chemical information learnable by AI. The potential of capturing more sophisticated chemical information better into a new ‘molecular language’ is still untapped and bears promise to revolutionize molecular AI. ReMINDER will break with traditional approaches and shift the object of study from increasingly complex algorithms to novel molecular representation paradigms for AI. ReMINDER will be an agent of change in the molecular AI landscape, by developing a new representation framework at the interface between method development and experimental validation. ReMINDER will disrupt the potential of AI to (a) navigate complex structure-activity landscapes, (b) design innovative bioactive molecules from scratch, (c) leverage binding pocket information for molecule discovery. By transforming the chemical information captured for AI, we open opportunities to develop more efficient models and solve open scientific challenges. ReMINDER will create the basis for exciting new technology in the field of deep learning for drug discovery, and chemistry at large.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data